Deborah Mattson
Medical · Belleair, FLNPI 1346394624
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.7%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Boehringer Ingelheim accounts for 63.8% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2024 at $7,432 and has fallen 95.4% since, to $340 in 2025. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $44.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$11K
- AstraZeneca$1K
- Insmed, Inc.$603
- Amgen$417
- Regeneron Healthcare Solutions, Inc.$406
- GSK$374
- plus $3K from 26 others
What the payments were for
- Consulting fees$3,33020%
- Speaking & faculty fees$4,17525%
- Travel & lodging$1,5129%
- Food & beverage$7,63846%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 80 | $10,661 |
| AstraZeneca(2 entities) | 48 | $1,231 |
| Insmed, Inc. | 38 | $603 |
| Amgen | 29 | $417 |
| Regeneron Healthcare Solutions, Inc. | 25 | $406 |
| GSK | 17 | $374 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $336 |
| Harmony Biosciences LLC | 16 | $314 |
| Actelion Pharmaceuticals US, Inc. | 13 | $303 |
| Grifols USA, LLC | 12 | $246 |
| Sanofi | 10 | $173 |
| United Therapeutics Corporation | 7 | $153 |
| AbbVie | 7 | $152 |
| Electromed, Inc. | 11 | $144 |
| Neurocrine Biosciences, Inc. | 1 | $135 |
| Mylan Specialty L.p. | 5 | $115 |
| Bayer | 6 | $109 |
| Stryker | 1 | $100 |
| Novartis | 4 | $94 |
| Shionogi Inc | 5 | $91 |
| Vapotherm Inc | 4 | $84 |
| Baxter Healthcare | 4 | $83 |
| Neurelis, Inc. | 1 | $82 |
| Merck | 5 | $70 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $51 |
| Inspire Medical Systems, Inc. | 1 | $49 |
| Johnson & Johnson | 3 | $45 |
| Pulmonx Corporation | 1 | $28 |
| Inogen, Inc. | 2 | $25 |
| Pfizer | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| 3b Medical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,716 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $65,167 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $22,949 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $16,894 |
| EliquisApixaban | 19 | $12,043 |
| Spiriva RespimatTiotropium Bromide | 17 | $9,920 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $6,881 |
| BreynaBudesonide/Formoterol Fumarate | 19 | $5,319 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $2,383 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 86 | $1,649 |
| Famotidine | 25 | $204 |
| Montelukast Sodium | 13 | $142 |
| Prednisone | 43 | $139 |
| Methylprednisolone | 19 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $374 | $82,061100 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,231 | $29,83055 claims |
| PfizerEliquis | $18 | $12,04319 claims |
| Boehringer IngelheimSpiriva Respimat | $10,661 | $9,92017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.
Other medical in Belleair
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.